These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25636178)

  • 1. Forecasting psychosis by event-related potentials-systematic review and specific meta-analysis.
    Bodatsch M; Brockhaus-Dumke A; Klosterkötter J; Ruhrmann S
    Biol Psychiatry; 2015 Jun; 77(11):951-8. PubMed ID: 25636178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Event-Related Potentials in the Clinical High-Risk (CHR) State for Psychosis: A Systematic Review.
    Lepock JR; Mizrahi R; Korostil M; Bagby RM; Pang EW; Kiang M
    Clin EEG Neurosci; 2018 Jul; 49(4):215-225. PubMed ID: 29382210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurophysiological alterations in the prepsychotic phases.
    Crossley NA; Constante M; Fusar-Poli P; Bramon E
    Curr Pharm Des; 2012; 18(4):479-85. PubMed ID: 22239578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Remission in Subjects at Clinical High Risk for Psychosis Using Mismatch Negativity.
    Kim M; Lee TH; Yoon YB; Lee TY; Kwon JS
    Schizophr Bull; 2018 Apr; 44(3):575-583. PubMed ID: 29036493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auditory event-related potential of subjects with suspected pre-psychotic state and first-episode psychosis.
    Hsieh MH; Shan JC; Huang WL; Cheng WC; Chiu MJ; Jaw FS; Hwu HG; Liu CC
    Schizophr Res; 2012 Sep; 140(1-3):243-9. PubMed ID: 22784684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis.
    Koshiyama D; Kirihara K; Tada M; Nagai T; Koike S; Suga M; Araki T; Kasai K
    Schizophr Res; 2017 Dec; 190():32-38. PubMed ID: 28314681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatch negativity (MMN) deficiency: a break-through biomarker in predicting psychosis onset.
    Näätänen R; Shiga T; Asano S; Yabe H
    Int J Psychophysiol; 2015 Mar; 95(3):338-44. PubMed ID: 25562834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Mismatch Negativity to Investigate the Pathophysiology of Substance Use Disorders and Comorbid Psychosis.
    Ramlakhan JU; Zomorrodi R; Downar J; Blumberger DM; Daskalakis ZJ; George TP; Kiang M; Barr MS
    Clin EEG Neurosci; 2018 Jul; 49(4):226-237. PubMed ID: 29502434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD.
    Rydkjær J; Møllegaard Jepsen JR; Pagsberg AK; Fagerlund B; Glenthøj BY; Oranje B
    Psychol Med; 2017 Jan; 47(2):377-388. PubMed ID: 27776572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations.
    Hermens DF; Ward PB; Hodge MA; Kaur M; Naismith SL; Hickie IB
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):822-9. PubMed ID: 20302901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroencephalography and Event-Related Potential Biomarkers in Individuals at Clinical High Risk for Psychosis.
    Hamilton HK; Boos AK; Mathalon DH
    Biol Psychiatry; 2020 Aug; 88(4):294-303. PubMed ID: 32507388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forecasting Remission From the Psychosis Risk Syndrome With Mismatch Negativity and P300: Potentials and Pitfalls.
    Hamilton HK; Roach BJ; Mathalon DH
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Feb; 6(2):178-187. PubMed ID: 33431345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis.
    Atkinson RJ; Michie PT; Schall U
    Biol Psychiatry; 2012 Jan; 71(2):98-104. PubMed ID: 22000060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of psychosis by mismatch negativity.
    Bodatsch M; Ruhrmann S; Wagner M; Müller R; Schultze-Lutter F; Frommann I; Brinkmeyer J; Gaebel W; Maier W; Klosterkötter J; Brockhaus-Dumke A
    Biol Psychiatry; 2011 May; 69(10):959-66. PubMed ID: 21167475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismatch negativity (MMN) as biomarker predicting psychosis in clinically at-risk individuals.
    Näätänen R; Todd J; Schall U
    Biol Psychol; 2016 Apr; 116():36-40. PubMed ID: 26542526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review.
    Nagai T; Tada M; Kirihara K; Araki T; Jinde S; Kasai K
    Front Psychiatry; 2013 Sep; 4():115. PubMed ID: 24069006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensory prediction errors in the continuum of psychosis.
    Randeniya R; Oestreich LKL; Garrido MI
    Schizophr Res; 2018 Jan; 191():109-122. PubMed ID: 28457774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode.
    van Tricht MJ; Nieman DH; Koelman JT; Mensink AJ; Bour LJ; van der Meer JN; van Amelsvoort TA; Linszen DH; de Haan L
    World J Biol Psychiatry; 2015 Jan; 16(1):12-21. PubMed ID: 22730901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant temporal behavior of mismatch negativity generators in schizophrenia patients and subjects at clinical high risk for psychosis.
    Kim M; Cho KI; Yoon YB; Lee TY; Kwon JS
    Clin Neurophysiol; 2017 Feb; 128(2):331-339. PubMed ID: 28056388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting coma and other low responsive patients outcome using event-related brain potentials: a meta-analysis.
    Daltrozzo J; Wioland N; Mutschler V; Kotchoubey B
    Clin Neurophysiol; 2007 Mar; 118(3):606-14. PubMed ID: 17208048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.